drugset
drugset / Trial / NCT07683429

Local Corticosteroid Injection Versus Open Surgical Release in De Quervain Tenosynovitis: A Single-Center Study

NCT07683429 ↗

Completed 100 enrolled Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi
Non-randomizedParallel-groupSingle-blindTreatment

Summary

This quasi-experimental study compared pain outcomes following local corticosteroid injection (CSI) versus open surgical release in 100 patients with clinically confirmed De Quervain tenosynovitis unresponsive to conservative management. Patients were allocated to treatment based on clinician judgment and patient preference. Pain was assessed using the Visual Analog Scale (VAS) at baseline, one month, and six months post-intervention. The study was conducted at a single tertiary care centre in Rawalpindi, Pakistan between March 2023 and April 2025.

Timeline

Start
2023-03-03
Primary completion
2025-04-03
Completion
2025-04-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 40 mg Other
Comparator Lidocaine Other / unclassified 1 % Other

Indications

de Quervain disease